We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Accelerant Going Private Just One Year After Its IPO?
Read MoreHide Full Article
Key Takeaways
Accelerant agreed to Thoma Bravo's $4 billion-plus acquisition, sending shares up nearly 44%.
Accelerant's Q2 revenues rose 62.9% to $356.9 million, while net income jumped to $80 million.
Shareholders will receive $20.25 per share, a 49% premium despite remaining below the IPO price.
Accelerant Holdings (ARX - Free Report) , which went public just over a year ago, recently agreed to be acquired by Thoma Bravo and become a privately held company. The all-cash deal carries an enterprise value of more than $4 billion. Shares of the company jumped nearly 44% following the announcement on Aug. 13, 2026.
Accelerant priced its IPO at $21 per share in July 2025. But the stock subsequently struggled and traded well below the IPO price, reaching as low as about $9.18 earlier in 2026. Investor concerns regarding its complicated insurance structure and AI-driven disruption potential weighed on the stock. According to the new deal, Class A and Class B shareholders will receive $20.25 in cash for each share, a 49% premium to the Aug. 12 price, but still slightly below ARX's original IPO price.
Meanwhile, the underlying business was improving, creating a notable disconnect between operating performance and the stock’s valuation. In second-quarter 2026, revenues reached $356.9 million, up 62.9% year over year, while net income jumped to $80 million from $13.1 million. Adjusted EBITDA rose to $93.1 million, and Exchange Written Premium increased 23% to $1.32 billion. Against that backdrop, the acquisition offer gives shareholders an opportunity to exit at a substantial premium while still valuing ARX below its IPO price.
Accelerant’s independent Special Committee recommended the transaction, and the board approved it unanimously. The deal is expected to be closed in the first half of 2027. Altamont Capital Partners, which holds about 82% of voting rights, has agreed to support the transaction and retain some equity ownership alongside Thoma Bravo.
For the acquirer, the deal provides a way to back Accelerant’s data-driven specialty insurance marketplace and invest further in its technology, data and capital capacity. The agreement also removes public-market pressure while giving management more room to focus on long-term growth opportunities.
ARX’s Price Performance
Accelerant shares have gained 19.7% year to date, thanks to the jump following the acquisition announcement, against the industry’s 3.8% decline.
The Zacks Consensus Estimate for CNO Financial’s current-year earnings is pegged at $4.74 per share, which indicates 16.2% year-over-year growth. It has witnessed two upward estimate revisions against none in the opposite direction in the past 30 days. CNO beat earnings estimates in each of the last four quarters, with an average surprise of 23.2%.
The consensus mark for Horace Mann Educators’ current-year earnings is pegged at $4.78 per share, which has witnessed two upward revisions over the past 30 days and no movement in the opposite direction. Furthermore, the consensus estimate for HMN’s 2026 revenues indicates a 3.9% year-over-year increase.
The Zacks Consensus Estimate for Ategrity Specialty’s current year earnings is pegged at $2.16 per share, which indicates 34.2% year-over-year growth. It has witnessed one upward estimate revision against none in the opposite direction in the past month. ASIC beat earnings estimates in the last four quarters, with an average surprise of 30.2%.
Image: Bigstock
Why Is Accelerant Going Private Just One Year After Its IPO?
Key Takeaways
Accelerant Holdings (ARX - Free Report) , which went public just over a year ago, recently agreed to be acquired by Thoma Bravo and become a privately held company. The all-cash deal carries an enterprise value of more than $4 billion. Shares of the company jumped nearly 44% following the announcement on Aug. 13, 2026.
Accelerant priced its IPO at $21 per share in July 2025. But the stock subsequently struggled and traded well below the IPO price, reaching as low as about $9.18 earlier in 2026. Investor concerns regarding its complicated insurance structure and AI-driven disruption potential weighed on the stock. According to the new deal, Class A and Class B shareholders will receive $20.25 in cash for each share, a 49% premium to the Aug. 12 price, but still slightly below ARX's original IPO price.
Meanwhile, the underlying business was improving, creating a notable disconnect between operating performance and the stock’s valuation. In second-quarter 2026, revenues reached $356.9 million, up 62.9% year over year, while net income jumped to $80 million from $13.1 million. Adjusted EBITDA rose to $93.1 million, and Exchange Written Premium increased 23% to $1.32 billion. Against that backdrop, the acquisition offer gives shareholders an opportunity to exit at a substantial premium while still valuing ARX below its IPO price.
Accelerant’s independent Special Committee recommended the transaction, and the board approved it unanimously. The deal is expected to be closed in the first half of 2027. Altamont Capital Partners, which holds about 82% of voting rights, has agreed to support the transaction and retain some equity ownership alongside Thoma Bravo.
For the acquirer, the deal provides a way to back Accelerant’s data-driven specialty insurance marketplace and invest further in its technology, data and capital capacity. The agreement also removes public-market pressure while giving management more room to focus on long-term growth opportunities.
ARX’s Price Performance
Accelerant shares have gained 19.7% year to date, thanks to the jump following the acquisition announcement, against the industry’s 3.8% decline.
Zacks Rank & Other Key Picks
Accelerant currently has a Zacks Rank #2 (Buy). Some other top-ranked stocks in the broader Finance space are CNO Financial Group, Inc. (CNO - Free Report) , Horace Mann Educators Corporation (HMN - Free Report) and Ategrity Specialty Insurance Company Holdings (ASIC - Free Report) , each carrying a Zacks Rank #2 at present as well. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CNO Financial’s current-year earnings is pegged at $4.74 per share, which indicates 16.2% year-over-year growth. It has witnessed two upward estimate revisions against none in the opposite direction in the past 30 days. CNO beat earnings estimates in each of the last four quarters, with an average surprise of 23.2%.
The consensus mark for Horace Mann Educators’ current-year earnings is pegged at $4.78 per share, which has witnessed two upward revisions over the past 30 days and no movement in the opposite direction. Furthermore, the consensus estimate for HMN’s 2026 revenues indicates a 3.9% year-over-year increase.
The Zacks Consensus Estimate for Ategrity Specialty’s current year earnings is pegged at $2.16 per share, which indicates 34.2% year-over-year growth. It has witnessed one upward estimate revision against none in the opposite direction in the past month. ASIC beat earnings estimates in the last four quarters, with an average surprise of 30.2%.